Longitude Capital Partners II LLC 13D and 13G filings for Kala Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-10-18 4:04 pm Unchanged | 2023-05-01 | 13D | Kala Pharmaceuticals, Inc. KALA | Longitude Capital Partners II LLC | 108,239 4.300% | 0 (Unchanged) | Filing |
| 2023-02-14 4:15 pm Sale | 2022-12-31 | 13D | Kala Pharmaceuticals, Inc. KALA | Longitude Capital Partners II LLC | 108,239 6.300% | -110,042 (-50.41%) | Filing |